Oxford BioMedica (GB:OXB) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Oxford Biomedica has announced its total voting rights, with its issued share capital comprising 105,938,933 ordinary shares, reflecting its strategic position as a leader in cell and gene therapy. The company, renowned for its innovation in viral vector manufacturing, collaborates with top pharmaceutical firms globally. As a FTSE4Good constituent, OXB continues to drive advancements in the biotech sector from its multiple facilities across the UK, France, and the US.
For further insights into GB:OXB stock, check out TipRanks’ Stock Analysis page.
